Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · technology

Boehringer, Microsoft team up to explore digital patient twins for clinical trials

26 October 2026 · By · Wire by Fusion42

Published

26 October 2026

Topic

technology

◆ Sectors

Digital HealthAI Frontier ModelsBiotech

◆ Geography

GermanyUnited States

◆ Source

Read at fiercebiotech.com →

◆ Verified

Fusion42 · 26 October 2026 · Fusion42 review

Boehringer Ingelheim and Microsoft have launched a collaboration to explore AI-powered digital patient twins to improve clinical trial design and efficiency, focusing initially on lung health.

This Wire brief sits within Fusion42's coverage of Digital Health, AI Frontier Models and Biotech.

◆ ◆ The Wire takeaway

You can tap into AI to create synthetic control groups that cut patient needs and speed trials. This opens doors to faster drug development and patient access if you focus on digital patient tools.

◆ Coverage

1 source · 26 Oct 2026

◆ Related on Wire

◆ Topics

Digital HealthAI Frontier ModelsBiotechdigital-twinsclinical-trialsAIdrug-developmentpatient-centric